Clinical Trial Update: Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke [Phase 2]

View source ↗

Summary

Phase 2 randomized trial of argatroban with tissue plasminogen activator (tPA) for acute ischemic stroke. The study was terminated and results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)
• Argatroban (argatroban)

Snippet

Sponsor: Andrew D. Barreto, MD | Conditions: Ischemic Stroke | Phase 2 | Status: TERMINATED | Results posted: 2017-05-11